MedPath

BAKER HEART AND DIABETES INSTITUTE

BAKER HEART AND DIABETES INSTITUTE logo
🇦🇺Australia
Ownership
-
Established
1858-01-01
Employees
481
Market Cap
-
Website
http://www.bakeru.edu

Clinical Trials

52

Active:2
Completed:14

Trial Phases

4 Phases

Phase 1:1
Phase 2:1
Phase 4:16
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (45 trials with phase data)• Click on a phase to view related trials

Not Applicable
27 (60.0%)
Phase 4
16 (35.6%)
Phase 1
1 (2.2%)
Phase 2
1 (2.2%)

Exercise to Improve Neurovascular Function in Breast Cancer Survivors

Not Applicable
Not yet recruiting
Conditions
Breast Cancer Survivorship
First Posted Date
2025-04-13
Last Posted Date
2025-04-13
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
40
Registration Number
NCT06925529
Locations
🇦🇺

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Real-World Evaluation of a Digitally Enabled Cardiac Rehabilitation Program

Completed
Conditions
Chronic Disease
Cardiovascular Disease Prevention
Heart Disease
First Posted Date
2025-02-07
Last Posted Date
2025-02-07
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
172
Registration Number
NCT06813482
Locations
🇦🇺

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Echo Acquisition Despite Geographic Separation by Replication of Human Movements (EAGER)

Not Applicable
Not yet recruiting
Conditions
Echocardiography
First Posted Date
2024-12-19
Last Posted Date
2024-12-19
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
50
Registration Number
NCT06742905
Locations
🇦🇺

Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor

Not Applicable
Recruiting
Conditions
Cognitive Impairment
Left Ventricular Dysfunction
Heart Failure
Dementia
Cognitive Change
Cognitive Decline
First Posted Date
2023-10-18
Last Posted Date
2024-08-12
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
168
Registration Number
NCT06088212
Locations
🇦🇺

Menzies Institute for Medical Research, Hobart, Tasmania, Australia

Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment

Not Applicable
Recruiting
Conditions
Heart Failure
Valve Heart Disease
First Posted Date
2022-09-28
Last Posted Date
2024-08-22
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
612
Registration Number
NCT05558605
Locations
🇦🇺

Alice Springs Hospital, Alice Springs, Northern Territory, Australia

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

Glucotrack Secures Ethical Approval for Long-Term Clinical Study of Implantable Blood Glucose Monitor

Glucotrack has received ethical approval from St. Vincent's Hospital Melbourne HREC for a year-long clinical study of its implantable continuous blood glucose monitor in patients with type 1 and type 2 diabetes.

© Copyright 2025. All Rights Reserved by MedPath